Skip to main content

Advertisement

Table 2 Cardiovascular events among propensity score-matched MSU crystal exposed and unexposed individuals

From: Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study

  MSU crystals No MSU crystals HR (95 % CI) HR (95 % CI)
(events / person-year) (events / person-year) no stratification by urate level stratified by urate level
APTC 46 / 1026 34 / 1009 1.33 (0.85–2.07) 0.86 (0.52–1.43)
Nonfatal MI 11 / 1026 9 / 1009 1.22 (0.50–2.94) 1.04 (0.37–2.90)
Nonfatal stroke 17 / 1026 11 / 1009 1.50 (0.70–3.20) 1.13 (0.49–2.61)
CV death 18 / 1026 14 / 1009 1.27 (0.63–2.56) 0.59 (0.26–1.32)
All-cause mortality 46 / 1026 40 / 1009 1.14 (0.75–1.74) 0.74 (0.45–1.21)
  1. APTC AntiPlatelet Trialists’ Collaboration, CI confidence interval, CV cardiovascular, HR Hazard ratio, MI myocardial infarction, MSU monosodium urate
  2. The no-crystal group was set as reference